Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Jan;79(2):601–605. doi: 10.1073/pnas.79.2.601

Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.

D H Meshulam, H E Blair, B L Wong, S Charm, J Minowada, R E Rocklin
PMCID: PMC345793  PMID: 6952211

Abstract

Leukocyte inhibitory factor (LIF), a lymphokine that inhibits the random and directed migration of polymorphonuclear (PMN) leukocytes, was purified from a human non-T, non-B leukemia cell line (Reh). From 10 liters of serum-free supernatant, 1.3 microgram of protein with LIF activity was obtained by the sequential use of affinity chromatography with concanavalin A-Sepharose, hydrophobic chromatography with hexylagarose, and gel filtration chromatography. The specific activity of LIF recovered represented an 80,000-fold purification over that of the initial crude serum-free supernatants, and the preparation at that point was estimated to be 80--90% pure. To both assess the purity of the preparation and provide a further purification step, Reh LIF activity recovered by the above procedures was subjected to isoelectric focusing. One major stainable protein band was identified; its isoelectric point was pH 5.4--5.5. Gels run in parallel for recovery of biologic activity revealed only one region (pH 5.4--5.5) with ability to inhibit PMN leukocyte migration. Iodination of Reh LIF resulted in a loss of biologic activity, but isoelectric focusing of this material revealed one major 125I-labeled band (pH 5.1) and several minor bands. The coincidence of biologic LIF activity with one stainable protein band as identified by isoelectric focusing implies that the final product may be homogeneous.

Full text

PDF
601

Images in this article

604Image
on p.604

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendtzen K. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides. Scand J Immunol. 1977;6(10):1055–1062. [PubMed] [Google Scholar]
  2. Bendtzen K., Mahoney R., Rocklin R. E. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors. Clin Immunol Immunopathol. 1981 Feb;18(2):212–220. doi: 10.1016/0090-1229(81)90027-1. [DOI] [PubMed] [Google Scholar]
  3. Bendtzen K., Rocklin R. E. Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF). J Immunol. 1980 Oct;125(4):1775–1781. [PubMed] [Google Scholar]
  4. Bendtzen K. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF). Acta Pathol Microbiol Scand C. 1976 Dec;84C(6):471–476. doi: 10.1111/j.1699-0463.1976.tb00057.x. [DOI] [PubMed] [Google Scholar]
  5. Clausen J. E. Migration inhibitory effect of cell-free supernatants from mixed human lymphocyte cultures. J Immunol. 1972 Feb;108(2):453–459. [PubMed] [Google Scholar]
  6. De Bernardo S., Weigele M., Toome V., Manhart K., Leimgruber W., Böhlen P., Stein S., Udenfriend S. Studies on the reaction of fluorescamine with primary amines. Arch Biochem Biophys. 1974 Jul;163(1):390–399. doi: 10.1016/0003-9861(74)90490-1. [DOI] [PubMed] [Google Scholar]
  7. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Oakley B. R., Kirsch D. R., Morris N. R. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem. 1980 Jul 1;105(2):361–363. doi: 10.1016/0003-2697(80)90470-4. [DOI] [PubMed] [Google Scholar]
  10. Righetti P., Drysdale J. W. Isoelectric focusing in polyacrylamide gels. Biochim Biophys Acta. 1971 Apr 27;236(1):17–28. doi: 10.1016/0005-2795(71)90144-9. [DOI] [PubMed] [Google Scholar]
  11. Rocklin R. E., Bendtzen K., Greineder D. Mediators of immunity: lymphokines and monokines. Adv Immunol. 1980;29:55–136. doi: 10.1016/s0065-2776(08)60043-7. [DOI] [PubMed] [Google Scholar]
  12. Rocklin R. E., Blidy A., Butler J., Minowada J. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity. J Immunol. 1981 Aug;127(2):534–539. [PubMed] [Google Scholar]
  13. Rocklin R. E. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A). J Immunol. 1975 Apr;114(4):1161–1165. [PubMed] [Google Scholar]
  14. Rocklin R. E. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol. 1974 Apr;112(4):1461–1466. [PubMed] [Google Scholar]
  15. Rocklin R. E., Rosenthal A. S. Evidence that human leukocyte inhibitory factor (LIF) is an esterase. J Immunol. 1977 Jul;119(1):249–252. [PubMed] [Google Scholar]
  16. Rocklin R. E., Urbano A. M. Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity. J Immunol. 1978 Apr;120(4):1409–1414. [PubMed] [Google Scholar]
  17. Stein S., Böhlen P., Stone J., Dairman W., Udenfriend S. Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys. 1973 Mar;155(1):202–212. doi: 10.1016/s0003-9861(73)80022-0. [DOI] [PubMed] [Google Scholar]
  18. Udenfriend S., Stein S., Böhlen P., Dairman W., Leimgruber W., Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science. 1972 Nov 24;178(4063):871–872. doi: 10.1126/science.178.4063.871. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES